🚀 Club degli Investitori invests in Evergreen Theragnostic’s $26 million round!

Club degli Investitori announces its involvement in the third investment round of Evergreen Theragnostics, a pharmaceutical company, a leader in the research and development of radiopharmaceuticals for oncology treatment that saw a record $26 million raised from international investors, with the key support of the Investors’ Club.

This investment would not have been possible without the outstanding support of Enrico De Maria, our Champion, whose commitment played a key role in achieving this milestone. His active contribution and dedication made this significant investment possible.

🧪Since 2020, Club degli Investitori has invested approximately $5 million in Evergreen Theragnostics, demonstrating continued confidence in the company’s innovative potential. This funding represents a new chapter in the fruitful collaboration between the two entities, pushing forward Evergreen’s R&D pipeline, preparing it for the launch of its first commercial product, and strengthening CDMO services.

#newinvestment #EvergreenTheragnostics #ClubDegliInvestitori